| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/26/2006 | CN1806847A Gene engineering preparation method of human pancreas secreted trypsin inhibitor |
| 07/26/2006 | CN1265840C Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5 |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/25/2006 | US7081518 For the diagnosis and therapy of cancers of the ovary, stomach, squamous cells, mesotheliomas and other malignant cells expressing mesothelin |
| 07/25/2006 | US7081517 Nucleotide sequences coding for use in detection of mamary gland cancer |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081495 Cationic compounds and their use as macro molecular carriers |
| 07/25/2006 | US7081451 On solid adsorbent supports; loading process can take place continuously over a period of weeks until the column is saturated |
| 07/25/2006 | US7081447 Organic compounds with biological activity as thrombin inhibitors and use thereof |
| 07/25/2006 | US7081446 Long-acting follicle stimulating hormone analogues and uses thereof |
| 07/25/2006 | US7081445 Cyclosporin galenic forms |
| 07/25/2006 | US7081444 an octapeptide that selectively activates the Receptors for Activated C-Kinase (RACK) in cardiomyocytes and is linked to a tat-peptide or polyarginine peptide; peptide can be administered before, during or after the ischemic or hypoxic event; antiischemic, antihypoxic agents |
| 07/25/2006 | US7081443 A fusion proteins comprising a cyclic peptide linked to a receptor as a cell growth factors, promoting cell proliferation, cell antiproliferative agents; soluble, potent |
| 07/25/2006 | US7081442 Composition containing a peptide and a pigment and the use thereof in darkening the skin |
| 07/25/2006 | US7081360 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 07/25/2006 | US7081354 Interleukin and albumin fusion protein |
| 07/25/2006 | US7081345 For use in diagnostic, prognostic, prophylactic or therapeutic formulation |
| 07/25/2006 | US7081344 Methods for screening compounds that bind human COE-2 |
| 07/25/2006 | US7081338 DNA coding for a novel cell adhesion molecule |
| 07/25/2006 | US7081245 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/25/2006 | US7081242 Administering conjugate comprising (a) a non-immunogenic valency platform molecule and (b) two or more molecules comprising double stranded DNA (dsDNA) epitopes, wherein the dsDNA epitopes are polynucleotides which specifically bind to an antibody from the individual |
| 07/25/2006 | US7081241 Extracellular rage binding protein (EN-RAGE) and uses thereof |
| 07/25/2006 | US7081240 Protein mixtures for wound healing |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | CA2206423C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 07/25/2006 | CA2072785C Pharmacologically active hydrazine derivatives and processes for the preparation thereof |
| 07/20/2006 | WO2006076692A1 Compositions for buccal delivery of parathyroid hormone |
| 07/20/2006 | WO2006076673A2 Use of il-i antagonists to treat polymyalgia rheumatica and giant cell arteritis |
| 07/20/2006 | WO2006076588A1 Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease |
| 07/20/2006 | WO2006076523A1 Modified beta thymosin peptides |
| 07/20/2006 | WO2006076453A2 METHOD FOR DELIVERING INTERFERON-β |
| 07/20/2006 | WO2006076277A1 Compositions and methods for increasing the bioavailability of pulmonarily administered insulin |
| 07/20/2006 | WO2006076255A2 Method of treating or preventing microbial eye infection |
| 07/20/2006 | WO2006076254A2 Method of treating or preventing respiratory microbial infection of respiratory tissue |
| 07/20/2006 | WO2006076119A2 Treatment of skin diseases |
| 07/20/2006 | WO2006076041A2 Pan-her antagonists and methods of use |
| 07/20/2006 | WO2006076014A2 Interferon-alpha constructs for use in the treatment of sars |
| 07/20/2006 | WO2006075988A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 07/20/2006 | WO2006075819A1 Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 07/20/2006 | WO2006075587A1 Csf-containing remedy to be administered in low dose |
| 07/20/2006 | WO2006075558A1 Egg-derived bone-strengthening composition |
| 07/20/2006 | WO2006075509A1 Endotoxin activity inhibitor |
| 07/20/2006 | WO2006075350A2 Use of the pof1 gene product for cosmetic and/or therapeutic use of skin associated disorders |
| 07/20/2006 | WO2006075138A2 Il-10 related peptides for wound healing |
| 07/20/2006 | WO2006075124A1 Somatostatin analogue formulations |
| 07/20/2006 | WO2006074802A1 Use of a trpc channel for the treatment of a cardiovascular disease |
| 07/20/2006 | WO2006074600A1 Modified exendins and uses thereof |
| 07/20/2006 | WO2006052775A3 Peptide anti - tumor agent |
| 07/20/2006 | WO2006047702A3 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| 07/20/2006 | WO2006046108A3 Diagnosis of male infertility by measuring tissue factor pathway inhibitor |
| 07/20/2006 | WO2006045750A3 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/20/2006 | WO2006044531A3 Antisense modulation of ptp1b expression |
| 07/20/2006 | WO2006036871A3 Plant pr-5 proteins as mammalian therapeutic agents |
| 07/20/2006 | WO2006036729A3 USE OF TGF-β ANTAGONISTS TO LIMIT NEPHROTOXICITY OF IMMUNOSUPPRESSIVE AGENTS |
| 07/20/2006 | WO2006034455A3 Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/20/2006 | WO2006034056A3 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 07/20/2006 | WO2006017180A3 Glycopeptide dimers and uses thereof |
| 07/20/2006 | WO2006014349A3 Method of producing fully carbamylated erythropoietin |
| 07/20/2006 | WO2006012541A3 Compositions and methods for treating excessive bleeding |
| 07/20/2006 | WO2006005706A3 Combination therapy for preventing or treating alzheimer's disease, and kit therefor |
| 07/20/2006 | WO2005120562A3 Structure-based receptor mimics targeted against bacterial superantigen toxins |
| 07/20/2006 | WO2005120553A3 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
| 07/20/2006 | WO2005111070A3 Mucin3 egf-like domains |
| 07/20/2006 | WO2005105148A3 Liquid growth hormone formulation |
| 07/20/2006 | WO2005094282B1 Combination therapy comprising cloretazinetm |
| 07/20/2006 | WO2005086578A3 Anti-inflammatory peptides and methods of use thereof |
| 07/20/2006 | WO2005085430A3 Adzymes and uses thereof |
| 07/20/2006 | WO2005081858A3 Parkin-associated complex for protecting post-mitotic neurons from excitotoxicity and uses thereof |
| 07/20/2006 | WO2005075508A3 Hyperactive stat molecules and their use in assays employing gene activation |
| 07/20/2006 | WO2005062929A3 Use of fc receptor polymorphisms as diagnostics for treatment strategies for immune-response disorders |
| 07/20/2006 | WO2005023195A3 Treatment of spinal cord injury |
| 07/20/2006 | WO2005016955A3 Nogo receptor antagonists |
| 07/20/2006 | WO2005003164A9 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 07/20/2006 | WO2004110368A3 Combination therapy for the treatment of hypertension |
| 07/20/2006 | WO2004024862A3 Yeast protein expression secretion system |
| 07/20/2006 | WO2004003165A3 Novel polynucleotide and polypeptide sequences and uses thereof |
| 07/20/2006 | WO2002092619A3 Modified growth hormone |
| 07/20/2006 | US20060162014 Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules |
| 07/20/2006 | US20060162004 ADAM-like protease disruptions, compositions and methods related thereto |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160995 Thrombopoietin proteins with improved properties |
| 07/20/2006 | US20060160994 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII; for use in the treatment of hemorrhagenic disturbances |
| 07/20/2006 | US20060160989 Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof |
| 07/20/2006 | US20060160948 Polymer-von Willebrand factor-conjugates |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 07/20/2006 | US20060160776 Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage |
| 07/20/2006 | US20060160761 Regulation of vascular endothelium using BMX tyrosine kinase |
| 07/20/2006 | US20060160760 Modulation of glucocorticoid receptor expression |
| 07/20/2006 | US20060160759 Influenza therapeutic |
| 07/20/2006 | US20060160757 RNA interference mediated inhibition hairless of (HR) gene expression using short interfering nucleic acid (siNA) |
| 07/20/2006 | US20060160749 Tripeptide and tetrapeptide thioethers |
| 07/20/2006 | US20060160748 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 07/20/2006 | US20060160747 Statine derivatives for the treatment of Alzheimer's disease II |
| 07/20/2006 | US20060160746 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 07/20/2006 | US20060160745 Agents for preventing postoperative recurrence of premenopausal breast cancer |
| 07/20/2006 | US20060160744 treating septic shock using RC-3095 (H-D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-psi-Leu-NH2 ) |
| 07/20/2006 | US20060160743 Pentapeptide having the amino acid sequence CRPPR (cysteine-arginine-proline-proline-arginine); peptides and peptidomimetics; cardiovascular disorders; drug and gene delivery; receptor binding assay |